81
Views
8
CrossRef citations to date
0
Altmetric
Original Research

Development and Validation of a Nomogram for Predicting Recurrence-Free Survival of Surgical Resected Retroperitoneal Liposarcoma

, , , &
Pages 6633-6639 | Published online: 24 Aug 2021

Figures & data

Table 1 Demographic, Clinicopathologic and Treatment Characteristics of All Patients, as Well as Patients in Training and Test Set

Table 2 Results of the Univariable Cox Models and Wald Test for Backward Selected Variables

Figure 1 Nomogram for 1-, 2- and 5-year recurrence-free survival in patients with retroperitoneal liposarcoma after surgery.

Figure 1 Nomogram for 1-, 2- and 5-year recurrence-free survival in patients with retroperitoneal liposarcoma after surgery.

Figure 2 Calibration plots for predicting 1-, 2- and 5-year recurrence-free survival in the training and test sets. X-axis: bootstrap-predicted survival; y-axis: actual outcome.

Figure 2 Calibration plots for predicting 1-, 2- and 5-year recurrence-free survival in the training and test sets. X-axis: bootstrap-predicted survival; y-axis: actual outcome.

Figure 3 Kaplan–Meier curves of recurrence-free survival for patients with retroperitoneal liposarcoma after surgery in the high- and low-risk groups. (A) Training set; (B) test set.

Figure 3 Kaplan–Meier curves of recurrence-free survival for patients with retroperitoneal liposarcoma after surgery in the high- and low-risk groups. (A) Training set; (B) test set.